Alector, Inc. Operating Lease, Expense
Alector, Inc. (ALEC) reported Operating Lease, Expense of $200.00 thousand for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2021-02-25
- Alector, Inc. operating lease, expense for the quarter ending 2019-09-30 was $200.00K, a 0.00% change year-over-year.
- Alector, Inc. operating lease, expense for the quarter ending 2018-12-31 was $300.00K.
- Alector, Inc. operating lease, expense for the quarter ending 2018-09-30 was $200.00K.
- Alector, Inc. operating lease, expense for the quarter ending 2018-06-30 was $300.00K.
- Alector, Inc. operating lease, expense for fiscal 2018 was $1.10M, a 0.00% change from fiscal 2017.
- Alector, Inc. operating lease, expense for fiscal 2017 was $1.10M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $200.00K 10-Q · filed 2019-11-12 | |||
| 2018-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $500.00K derived: sum of 2 quarters · filed 2021-02-25 | $800.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.10M 10-K · filed 2021-02-25 |
| 2018-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $500.00K derived: sum of 2 quarters · filed 2019-11-12 | $800.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $300.00K 10-Q · filed 2019-08-12 | $600.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $300.00K 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | $1.10M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |